Year |
Citation |
Score |
2020 |
Murphy JM, Rodriguez YAR, Jeong K, Ahn EE, Lim SS. Targeting focal adhesion kinase in cancer cells and the tumor microenvironment. Experimental & Molecular Medicine. PMID 32514188 DOI: 10.1038/s12276-020-0447-4 |
0.303 |
|
2013 |
DeKelver RC, Yan M, Ahn EY, Shia WJ, Speck NA, Zhang DE. Attenuation of AML1-ETO cellular dysregulation correlates with increased leukemogenic potential. Blood. 121: 3714-7. PMID 23426948 DOI: 10.1182/Blood-2012-11-465641 |
0.401 |
|
2012 |
Lo MC, Peterson LF, Yan M, Cong X, Jin F, Shia WJ, Matsuura S, Ahn EY, Komeno Y, Ly M, Ommen HB, Chen IM, Hokland P, Willman CL, Ren B, et al. Combined gene expression and DNA occupancy profiling identifies potential therapeutic targets of t(8;21) AML. Blood. 120: 1473-84. PMID 22740448 DOI: 10.1182/Blood-2011-12-395335 |
0.386 |
|
2012 |
Ahn E, Higashi T, Yan M, Matsuura S, Lo M, Shia W, Dekelver R, Zhang D. SON Regulates GATA-2 Through Transcriptional Control of the Mir-23a∼27a∼24-2 Cluster Blood. 120: 110-110. DOI: 10.1182/Blood.V120.21.110.110 |
0.324 |
|
2010 |
Matsuura S, Yan M, Ahn E, Lo M, Dangoor D, Matin M, Burgoyne P, Zhang D. Negative Effects of GM-CSF Signaling In t(8;21)-Induced Leukemia Blood. 116: 3163-3163. DOI: 10.1182/Blood.V116.21.3163.3163 |
0.389 |
|
2009 |
Pawar P, Ma L, Byon CH, Liu H, Ahn EY, Jhala N, Arnoletti JP, McDonald JM, Chen Y. Molecular mechanisms of tamoxifen therapy for cholangiocarcinoma: role of calmodulin. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 15: 1288-96. PMID 19228732 DOI: 10.1158/1078-0432.Ccr-08-1150 |
0.536 |
|
2009 |
Yan M, Ahn EY, Hiebert SW, Zhang DE. RUNX1/AML1 DNA-binding domain and ETO/MTG8 NHR2-dimerization domain are critical to AML1-ETO9a leukemogenesis. Blood. 113: 883-6. PMID 19036704 DOI: 10.1182/Blood-2008-04-153742 |
0.337 |
|
2008 |
Ahn EY, Yan M, Malakhova OA, Lo MC, Boyapati A, Ommen HB, Hines R, Hokland P, Zhang DE. Disruption of the NHR4 domain structure in AML1-ETO abrogates SON binding and promotes leukemogenesis. Proceedings of the National Academy of Sciences of the United States of America. 105: 17103-8. PMID 18952841 DOI: 10.1073/pnas.0802696105 |
0.337 |
|
2008 |
Park SE, Lee SW, Hossain MA, Kim MY, Kim MN, Ahn EY, Park YC, Suh H, Kim GY, Choi YH, Kim ND. A chenodeoxycholic derivative, HS-1200, induces apoptosis and cell cycle modulation via Egr-1 gene expression control on human hepatoma cells. Cancer Letters. 270: 77-86. PMID 18554781 DOI: 10.1016/j.canlet.2008.04.038 |
0.444 |
|
2008 |
Dayyani F, Wang J, Yeh JR, Ahn EY, Tobey E, Zhang DE, Bernstein ID, Peterson RT, Sweetser DA. Loss of TLE1 and TLE4 from the del(9q) commonly deleted region in AML cooperates with AML1-ETO to affect myeloid cell proliferation and survival. Blood. 111: 4338-47. PMID 18258796 DOI: 10.1182/Blood-2007-07-103291 |
0.333 |
|
2008 |
Ahn EY, Jiang Y, Zhang Y, Son EM, You S, Kang SW, Park JS, Jung JH, Lee BJ, Kim DK. Cytotoxicity of p-tyrosol and its derivatives may correlate with the inhibition of DNA replication initiation. Oncology Reports. 19: 527-34. PMID 18202803 DOI: 10.3892/Or.19.2.527 |
0.361 |
|
2008 |
Ahn E, Yan M, Malakhova OA, Boyapati A, Ommen HB, Hines R, Hokland P, Zhang D. Disruption of the NHR4 Domain Structure in AML1-ETO Abrogates Its Interaction with SON and Promotes AML1-ETO-Associated Leukemogenesis. Blood. 112: 936-936. DOI: 10.1182/Blood.V112.11.936.936 |
0.405 |
|
2008 |
Lo M, Peterson LF, Yan M, Ahn E, Ommen HB, Chen I, Hokland P, Willman CL, Zhang D. Identification of the JAK/STAT Signaling Pathway as a Valid Therapeutic Target of T(8;21) Acute Myeloid Leukemia Using Combined Gene Expression and Promoter Occupancy Profiling. Blood. 112: 3336-3336. DOI: 10.1182/Blood.V112.11.3336.3336 |
0.363 |
|
2007 |
Zhang Y, Ahn EY, Jiang Y, Kim DK, Kang SG, Wu C, Kang SW, Park JS, Son BW, Jung JH. 3-Chloro-2,5-dihydroxybenzyl alcohol activates human cervical carcinoma HeLa cell apoptosis by inducing DNA damage. International Journal of Oncology. 31: 1317-23. PMID 17982657 DOI: 10.3892/Ijo.31.6.1317 |
0.552 |
|
2007 |
Pan G, Ahn EY, Chen Y, Feng G, Reddy V, Jhala NC, McDonald JM. Reciprocal co-expression of Fas and Fas ligand in human cholangiocarcinoma. International Journal of Oncology. 31: 843-50. PMID 17786316 DOI: 10.3892/Ijo.31.4.843 |
0.635 |
|
2005 |
Wu X, Ahn EY, McKenna MA, Yeo H, McDonald JM. Fas binding to calmodulin regulates apoptosis in osteoclasts. The Journal of Biological Chemistry. 280: 29964-70. PMID 15965236 DOI: 10.1074/Jbc.M500710200 |
0.713 |
|
2004 |
Ahn EY, Lim ST, Cook WJ, McDonald JM. Calmodulin binding to the Fas death domain. Regulation by Fas activation. The Journal of Biological Chemistry. 279: 5661-6. PMID 14594800 DOI: 10.1074/Jbc.M311040200 |
0.622 |
|
2003 |
Ahn EY, Pan G, Oh JH, Tytler EM, McDonald JM. The combination of calmodulin antagonists and interferon-gamma induces apoptosis through caspase-dependent and -independent pathways in cholangiocarcinoma cells. The American Journal of Pathology. 163: 2053-63. PMID 14578204 DOI: 10.1016/S0002-9440(10)63563-8 |
0.718 |
|
2002 |
Ahn EY, Pan G, Vickers SM, McDonald JM. IFN-gammaupregulates apoptosis-related molecules and enhances Fas-mediated apoptosis in human cholangiocarcinoma. International Journal of Cancer. Journal International Du Cancer. 100: 445-51. PMID 12115528 DOI: 10.1002/Ijc.10516 |
0.702 |
|
2002 |
Vickers SM, Jhala NC, Ahn EY, McDonald JM, Pan G, Bland KI. Tamoxifen (TMX)/Fas induced growth inhibition of human cholangiocarcinoma (HCC) by gamma interferon (IFN-gamma). Annals of Surgery. 235: 872-8. PMID 12035045 DOI: 10.1097/00000658-200206000-00016 |
0.643 |
|
Show low-probability matches. |